De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care

C. de Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)

Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session: Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Session type: Poster Discussion
Number: 5008
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. de Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands). De-implementing inappropriate inhaled steroids use in Dutch COPD patients in primary care. 5008

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016


Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011


Characteristics of COPD patients treated with inhaled corticosteroid in primary care
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021

Inhaled steroids prescribing in patients with COPD in the community
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001

Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007


SABA and ICS use among mild asthma patients in UK primary care
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


Characteristics of COPD patients prescribed ICS managed in general practice vs. secondary care
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Discontinuation of inhaled corticosteroid treatment in patients with COPD diagnosed in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002

Inhaled corticosteroids are over prescribed in patients with COPD, attending hospital
Source: Eur Respir J 2006; 28: Suppl. 50, 429s
Year: 2006

Characteristics of patients receiving inhaled treatment in primary care
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009


Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005

Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function
Source: Eur Respir J 2005; 26: Suppl. 49, 294s
Year: 2005

Asthma-related resource use and costs for patients prescribed inhaled corticosteroids compared to leukotriene modifiers in clinical practice
Source: Annual Congress 2010 - Management of airway disease
Year: 2010


Reasons for inhaled corticosteroid non-adherence disclosed by African American adults during primary care visits for uncontrolled asthma
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Lung function, symptoms and prescription of inhaled steroids and long acting β2 agonists in patients managed by an integrated COPD team
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020



Asthma control among patients receiving inhaled corticosteroids in general practice in Thailand
Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma
Year: 2010